EW Radue
Impact in
-
- Multiple Sclerosis Research Studies
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
Papers in
-
- Multiple Sclerosis Research Studies 10
-
- Systemic Lupus Erythematosus Research 2
- Rheumatoid Arthritis Research and Therapies 2
- Co-authors
- Ludwig KapposStefan BorgwardtXavier MontalbánAna de VeraAnita Riecher‐RösslerPaul O’ConnorJack P. AntelGiancarlo Comi
- Journals
- Neurology (4 papers)Multiple Sclerosis Journal (4 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (1 paper)Translational Psychiatry (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- SwitzerlandUnited StatesCanada
In The Last Decade
EW Radue
14 papers receiving 653 citations
Peers
Comparison fields: 5 of 67
- Pathology and Forensic Medicine 330
- Psychiatry and Mental health 143
- Cognitive Neuroscience 159
- Neurology 121
- Rheumatology 106
Countries citing papers authored by EW Radue
This map shows the geographic impact of EW Radue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EW Radue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EW Radue more than expected).
Fields of papers citing papers by EW Radue
This network shows the impact of papers produced by EW Radue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EW Radue. The network helps show where EW Radue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside EW Radue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 36 | |
| 2 | 2015 | 31 | |
| 3 | Interferon beta-1b is effective and has a favourable safety profile in Chinese patients with relapsing forms of multiple sclerosis | 2014 | 0 |
| 4 | Disease control and safety in relapsing remitting multiple sclerosis (RRMS) patients switching from natalizumab to fingolimod: a 32-week, rater- and patient-blind, randomized, parallel-group study (TOFINGO) | 2013 | 7 |
| 5 | 2013 | 19 | |
| 6 | 2012 | 10 | |
| 7 | 2011 | 3 | |
| 8 | 2011 | 46 | |
| 9 | Quantitative Magnetization Transfer Imaging in Acute Stroke: A Follow Up Study Correlating Quantitative MRI with Respect of Severity of Stroke | 2010 | 3 |
| 10 | 2009 | 171 | |
| 11 | 2009 | 149 | |
| 12 | 2009 | 2 | |
| 13 | 2008 | 6 | |
| 14 | 2005 | 154 | |
| 15 | 2001 | 32 |
About EW Radue
EW Radue is a scholar working on Pathology and Forensic Medicine, Rheumatology, Speech and Hearing, Small Animals and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 669 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (10 papers), Sphingolipid Metabolism and Signaling (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Functional Brain Connectivity Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Voice and Speech Disorders (1 paper) and Research on Leishmaniasis Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (330 citations), Psychiatry and Mental health (143 citations), Cognitive Neuroscience (159 citations), Neurology (121 citations) and Rheumatology (106 citations). EW Radue has collaborated with scholars based in Switzerland, United States and Canada. Frequent co-authors include Ludwig Kappos, Stefan Borgwardt, Xavier Montalbán, Ana de Vera, Anita Riecher‐Rössler, Paul O’Connor, Jack P. Antel, Giancarlo Comi, H. Pöhlmann and Paul Allen. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Translational Psychiatry and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.